Global Neuropathic Eye Pain Market Growth (Status and Outlook) 2025-2031--LP INFORMATION, INC.

Global Neuropathic Eye Pain Market Growth (Status and Outlook) 2025-2031

Product Code: 1480880

Industry: Medical Care

Published: Apr 10,2025

Pages: 118

Delivery Time: 2-3 business days

Global Neuropathic Eye Pain Market Growth (Status and Outlook) 2025-2031

Product Code: 1480880

Industry: Medical Care

Published: Apr 10,2025

Pages: 118

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Neuropathic Eye Pain market size is predicted to grow from US$ 162 million in 2025 to US$ 197 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.

United States market for Neuropathic Eye Pain is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Neuropathic Eye Pain is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Neuropathic Eye Pain is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Neuropathic Eye Pain players cover OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Neuropathic Eye Pain Industry Forecast” looks at past sales and reviews total world Neuropathic Eye Pain sales in 2024, providing a comprehensive analysis by region and market sector of projected Neuropathic Eye Pain sales for 2025 through 2031. With Neuropathic Eye Pain sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuropathic Eye Pain industry.

This Insight Report provides a comprehensive analysis of the global Neuropathic Eye Pain landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neuropathic Eye Pain portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuropathic Eye Pain market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuropathic Eye Pain and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuropathic Eye Pain.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuropathic Eye Pain market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Steroids

    Antidepressants

    Anticonvulsants

    Opioids

    Others

Segmentation by Application:

    Clinic

    Hospital

    Others

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    OKYO Pharma

    Ocular Therapeutix, Inc.

    IACTA Pharmaceuticals, Inc.

    Sun Pharmaceutical Industries Ltd

    Novartis AG

    SALVAT

    AbbVie Inc

    Bausch &Lomb Incorporated

    Kala Pharmaceuticals

    Spectra Vision Care

    AlconLaboratories

    BRIM Biotechnology Inc

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Neuropathic Eye Pain Market Size (2020-2031)
        2.1.2 Neuropathic Eye Pain Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Neuropathic Eye Pain by Country/Region (2020, 2024 & 2031)
    2.2 Neuropathic Eye Pain Segment by Type
        2.2.1 Steroids
        2.2.2 Antidepressants
        2.2.3 Anticonvulsants
        2.2.4 Opioids
        2.2.5 Others
    2.3 Neuropathic Eye Pain Market Size by Type
        2.3.1 Neuropathic Eye Pain Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Neuropathic Eye Pain Market Size Market Share by Type (2020-2025)
    2.4 Neuropathic Eye Pain Segment by Application
        2.4.1 Clinic
        2.4.2 Hospital
        2.4.3 Others
    2.5 Neuropathic Eye Pain Market Size by Application
        2.5.1 Neuropathic Eye Pain Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Neuropathic Eye Pain Market Size Market Share by Application (2020-2025)

3 Neuropathic Eye Pain Market Size by Player
    3.1 Neuropathic Eye Pain Market Size Market Share by Player
        3.1.1 Global Neuropathic Eye Pain Revenue by Player (2020-2025)
        3.1.2 Global Neuropathic Eye Pain Revenue Market Share by Player (2020-2025)
    3.2 Global Neuropathic Eye Pain Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Neuropathic Eye Pain by Region
    4.1 Neuropathic Eye Pain Market Size by Region (2020-2025)
    4.2 Global Neuropathic Eye Pain Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Neuropathic Eye Pain Market Size Growth (2020-2025)
    4.4 APAC Neuropathic Eye Pain Market Size Growth (2020-2025)
    4.5 Europe Neuropathic Eye Pain Market Size Growth (2020-2025)
    4.6 Middle East & Africa Neuropathic Eye Pain Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Neuropathic Eye Pain Market Size by Country (2020-2025)
    5.2 Americas Neuropathic Eye Pain Market Size by Type (2020-2025)
    5.3 Americas Neuropathic Eye Pain Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Neuropathic Eye Pain Market Size by Region (2020-2025)
    6.2 APAC Neuropathic Eye Pain Market Size by Type (2020-2025)
    6.3 APAC Neuropathic Eye Pain Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Neuropathic Eye Pain Market Size by Country (2020-2025)
    7.2 Europe Neuropathic Eye Pain Market Size by Type (2020-2025)
    7.3 Europe Neuropathic Eye Pain Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Neuropathic Eye Pain by Region (2020-2025)
    8.2 Middle East & Africa Neuropathic Eye Pain Market Size by Type (2020-2025)
    8.3 Middle East & Africa Neuropathic Eye Pain Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Neuropathic Eye Pain Market Forecast
    10.1 Global Neuropathic Eye Pain Forecast by Region (2026-2031)
        10.1.1 Global Neuropathic Eye Pain Forecast by Region (2026-2031)
        10.1.2 Americas Neuropathic Eye Pain Forecast
        10.1.3 APAC Neuropathic Eye Pain Forecast
        10.1.4 Europe Neuropathic Eye Pain Forecast
        10.1.5 Middle East & Africa Neuropathic Eye Pain Forecast
    10.2 Americas Neuropathic Eye Pain Forecast by Country (2026-2031)
        10.2.1 United States Market Neuropathic Eye Pain Forecast
        10.2.2 Canada Market Neuropathic Eye Pain Forecast
        10.2.3 Mexico Market Neuropathic Eye Pain Forecast
        10.2.4 Brazil Market Neuropathic Eye Pain Forecast
    10.3 APAC Neuropathic Eye Pain Forecast by Region (2026-2031)
        10.3.1 China Neuropathic Eye Pain Market Forecast
        10.3.2 Japan Market Neuropathic Eye Pain Forecast
        10.3.3 Korea Market Neuropathic Eye Pain Forecast
        10.3.4 Southeast Asia Market Neuropathic Eye Pain Forecast
        10.3.5 India Market Neuropathic Eye Pain Forecast
        10.3.6 Australia Market Neuropathic Eye Pain Forecast
    10.4 Europe Neuropathic Eye Pain Forecast by Country (2026-2031)
        10.4.1 Germany Market Neuropathic Eye Pain Forecast
        10.4.2 France Market Neuropathic Eye Pain Forecast
        10.4.3 UK Market Neuropathic Eye Pain Forecast
        10.4.4 Italy Market Neuropathic Eye Pain Forecast
        10.4.5 Russia Market Neuropathic Eye Pain Forecast
    10.5 Middle East & Africa Neuropathic Eye Pain Forecast by Region (2026-2031)
        10.5.1 Egypt Market Neuropathic Eye Pain Forecast
        10.5.2 South Africa Market Neuropathic Eye Pain Forecast
        10.5.3 Israel Market Neuropathic Eye Pain Forecast
        10.5.4 Turkey Market Neuropathic Eye Pain Forecast
    10.6 Global Neuropathic Eye Pain Forecast by Type (2026-2031)
    10.7 Global Neuropathic Eye Pain Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Neuropathic Eye Pain Forecast

11 Key Players Analysis
    11.1 OKYO Pharma
        11.1.1 OKYO Pharma Company Information
        11.1.2 OKYO Pharma Neuropathic Eye Pain Product Offered
        11.1.3 OKYO Pharma Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 OKYO Pharma Main Business Overview
        11.1.5 OKYO Pharma Latest Developments
    11.2 Ocular Therapeutix, Inc.
        11.2.1 Ocular Therapeutix, Inc. Company Information
        11.2.2 Ocular Therapeutix, Inc. Neuropathic Eye Pain Product Offered
        11.2.3 Ocular Therapeutix, Inc. Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 Ocular Therapeutix, Inc. Main Business Overview
        11.2.5 Ocular Therapeutix, Inc. Latest Developments
    11.3 IACTA Pharmaceuticals, Inc.
        11.3.1 IACTA Pharmaceuticals, Inc. Company Information
        11.3.2 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Product Offered
        11.3.3 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 IACTA Pharmaceuticals, Inc. Main Business Overview
        11.3.5 IACTA Pharmaceuticals, Inc. Latest Developments
    11.4 Sun Pharmaceutical Industries Ltd
        11.4.1 Sun Pharmaceutical Industries Ltd Company Information
        11.4.2 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Product Offered
        11.4.3 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 Sun Pharmaceutical Industries Ltd Main Business Overview
        11.4.5 Sun Pharmaceutical Industries Ltd Latest Developments
    11.5 Novartis AG
        11.5.1 Novartis AG Company Information
        11.5.2 Novartis AG Neuropathic Eye Pain Product Offered
        11.5.3 Novartis AG Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 Novartis AG Main Business Overview
        11.5.5 Novartis AG Latest Developments
    11.6 SALVAT
        11.6.1 SALVAT Company Information
        11.6.2 SALVAT Neuropathic Eye Pain Product Offered
        11.6.3 SALVAT Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 SALVAT Main Business Overview
        11.6.5 SALVAT Latest Developments
    11.7 AbbVie Inc
        11.7.1 AbbVie Inc Company Information
        11.7.2 AbbVie Inc Neuropathic Eye Pain Product Offered
        11.7.3 AbbVie Inc Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 AbbVie Inc Main Business Overview
        11.7.5 AbbVie Inc Latest Developments
    11.8 Bausch &Lomb Incorporated
        11.8.1 Bausch &Lomb Incorporated Company Information
        11.8.2 Bausch &Lomb Incorporated Neuropathic Eye Pain Product Offered
        11.8.3 Bausch &Lomb Incorporated Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 Bausch &Lomb Incorporated Main Business Overview
        11.8.5 Bausch &Lomb Incorporated Latest Developments
    11.9 Kala Pharmaceuticals
        11.9.1 Kala Pharmaceuticals Company Information
        11.9.2 Kala Pharmaceuticals Neuropathic Eye Pain Product Offered
        11.9.3 Kala Pharmaceuticals Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 Kala Pharmaceuticals Main Business Overview
        11.9.5 Kala Pharmaceuticals Latest Developments
    11.10 Spectra Vision Care
        11.10.1 Spectra Vision Care Company Information
        11.10.2 Spectra Vision Care Neuropathic Eye Pain Product Offered
        11.10.3 Spectra Vision Care Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 Spectra Vision Care Main Business Overview
        11.10.5 Spectra Vision Care Latest Developments
    11.11 AlconLaboratories
        11.11.1 AlconLaboratories Company Information
        11.11.2 AlconLaboratories Neuropathic Eye Pain Product Offered
        11.11.3 AlconLaboratories Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 AlconLaboratories Main Business Overview
        11.11.5 AlconLaboratories Latest Developments
    11.12 BRIM Biotechnology Inc
        11.12.1 BRIM Biotechnology Inc Company Information
        11.12.2 BRIM Biotechnology Inc Neuropathic Eye Pain Product Offered
        11.12.3 BRIM Biotechnology Inc Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 BRIM Biotechnology Inc Main Business Overview
        11.12.5 BRIM Biotechnology Inc Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Neuropathic Eye Pain Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Neuropathic Eye Pain Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Steroids
 Table 4. Major Players of Antidepressants
 Table 5. Major Players of Anticonvulsants
 Table 6. Major Players of Opioids
 Table 7. Major Players of Others
 Table 8. Neuropathic Eye Pain Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 9. Global Neuropathic Eye Pain Market Size by Type (2020-2025) & ($ millions)
 Table 10. Global Neuropathic Eye Pain Market Size Market Share by Type (2020-2025)
 Table 11. Neuropathic Eye Pain Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 12. Global Neuropathic Eye Pain Market Size by Application (2020-2025) & ($ millions)
 Table 13. Global Neuropathic Eye Pain Market Size Market Share by Application (2020-2025)
 Table 14. Global Neuropathic Eye Pain Revenue by Player (2020-2025) & ($ millions)
 Table 15. Global Neuropathic Eye Pain Revenue Market Share by Player (2020-2025)
 Table 16. Neuropathic Eye Pain Key Players Head office and Products Offered
 Table 17. Neuropathic Eye Pain Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 18. New Products and Potential Entrants
 Table 19. Mergers & Acquisitions, Expansion
 Table 20. Global Neuropathic Eye Pain Market Size by Region (2020-2025) & ($ millions)
 Table 21. Global Neuropathic Eye Pain Market Size Market Share by Region (2020-2025)
 Table 22. Global Neuropathic Eye Pain Revenue by Country/Region (2020-2025) & ($ millions)
 Table 23. Global Neuropathic Eye Pain Revenue Market Share by Country/Region (2020-2025)
 Table 24. Americas Neuropathic Eye Pain Market Size by Country (2020-2025) & ($ millions)
 Table 25. Americas Neuropathic Eye Pain Market Size Market Share by Country (2020-2025)
 Table 26. Americas Neuropathic Eye Pain Market Size by Type (2020-2025) & ($ millions)
 Table 27. Americas Neuropathic Eye Pain Market Size Market Share by Type (2020-2025)
 Table 28. Americas Neuropathic Eye Pain Market Size by Application (2020-2025) & ($ millions)
 Table 29. Americas Neuropathic Eye Pain Market Size Market Share by Application (2020-2025)
 Table 30. APAC Neuropathic Eye Pain Market Size by Region (2020-2025) & ($ millions)
 Table 31. APAC Neuropathic Eye Pain Market Size Market Share by Region (2020-2025)
 Table 32. APAC Neuropathic Eye Pain Market Size by Type (2020-2025) & ($ millions)
 Table 33. APAC Neuropathic Eye Pain Market Size by Application (2020-2025) & ($ millions)
 Table 34. Europe Neuropathic Eye Pain Market Size by Country (2020-2025) & ($ millions)
 Table 35. Europe Neuropathic Eye Pain Market Size Market Share by Country (2020-2025)
 Table 36. Europe Neuropathic Eye Pain Market Size by Type (2020-2025) & ($ millions)
 Table 37. Europe Neuropathic Eye Pain Market Size by Application (2020-2025) & ($ millions)
 Table 38. Middle East & Africa Neuropathic Eye Pain Market Size by Region (2020-2025) & ($ millions)
 Table 39. Middle East & Africa Neuropathic Eye Pain Market Size by Type (2020-2025) & ($ millions)
 Table 40. Middle East & Africa Neuropathic Eye Pain Market Size by Application (2020-2025) & ($ millions)
 Table 41. Key Market Drivers & Growth Opportunities of Neuropathic Eye Pain
 Table 42. Key Market Challenges & Risks of Neuropathic Eye Pain
 Table 43. Key Industry Trends of Neuropathic Eye Pain
 Table 44. Global Neuropathic Eye Pain Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 45. Global Neuropathic Eye Pain Market Size Market Share Forecast by Region (2026-2031)
 Table 46. Global Neuropathic Eye Pain Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 47. Global Neuropathic Eye Pain Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 48. OKYO Pharma Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 49. OKYO Pharma Neuropathic Eye Pain Product Offered
 Table 50. OKYO Pharma Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 51. OKYO Pharma Main Business
 Table 52. OKYO Pharma Latest Developments
 Table 53. Ocular Therapeutix, Inc. Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 54. Ocular Therapeutix, Inc. Neuropathic Eye Pain Product Offered
 Table 55. Ocular Therapeutix, Inc. Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 56. Ocular Therapeutix, Inc. Main Business
 Table 57. Ocular Therapeutix, Inc. Latest Developments
 Table 58. IACTA Pharmaceuticals, Inc. Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 59. IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Product Offered
 Table 60. IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 61. IACTA Pharmaceuticals, Inc. Main Business
 Table 62. IACTA Pharmaceuticals, Inc. Latest Developments
 Table 63. Sun Pharmaceutical Industries Ltd Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 64. Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Product Offered
 Table 65. Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 66. Sun Pharmaceutical Industries Ltd Main Business
 Table 67. Sun Pharmaceutical Industries Ltd Latest Developments
 Table 68. Novartis AG Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 69. Novartis AG Neuropathic Eye Pain Product Offered
 Table 70. Novartis AG Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 71. Novartis AG Main Business
 Table 72. Novartis AG Latest Developments
 Table 73. SALVAT Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 74. SALVAT Neuropathic Eye Pain Product Offered
 Table 75. SALVAT Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 76. SALVAT Main Business
 Table 77. SALVAT Latest Developments
 Table 78. AbbVie Inc Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 79. AbbVie Inc Neuropathic Eye Pain Product Offered
 Table 80. AbbVie Inc Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 81. AbbVie Inc Main Business
 Table 82. AbbVie Inc Latest Developments
 Table 83. Bausch &Lomb Incorporated Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 84. Bausch &Lomb Incorporated Neuropathic Eye Pain Product Offered
 Table 85. Bausch &Lomb Incorporated Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 86. Bausch &Lomb Incorporated Main Business
 Table 87. Bausch &Lomb Incorporated Latest Developments
 Table 88. Kala Pharmaceuticals Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 89. Kala Pharmaceuticals Neuropathic Eye Pain Product Offered
 Table 90. Kala Pharmaceuticals Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 91. Kala Pharmaceuticals Main Business
 Table 92. Kala Pharmaceuticals Latest Developments
 Table 93. Spectra Vision Care Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 94. Spectra Vision Care Neuropathic Eye Pain Product Offered
 Table 95. Spectra Vision Care Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 96. Spectra Vision Care Main Business
 Table 97. Spectra Vision Care Latest Developments
 Table 98. AlconLaboratories Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 99. AlconLaboratories Neuropathic Eye Pain Product Offered
 Table 100. AlconLaboratories Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 101. AlconLaboratories Main Business
 Table 102. AlconLaboratories Latest Developments
 Table 103. BRIM Biotechnology Inc Details, Company Type, Neuropathic Eye Pain Area Served and Its Competitors
 Table 104. BRIM Biotechnology Inc Neuropathic Eye Pain Product Offered
 Table 105. BRIM Biotechnology Inc Neuropathic Eye Pain Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 106. BRIM Biotechnology Inc Main Business
 Table 107. BRIM Biotechnology Inc Latest Developments


List of Figures
 Figure 1. Neuropathic Eye Pain Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Neuropathic Eye Pain Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Neuropathic Eye Pain Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Neuropathic Eye Pain Sales Market Share by Country/Region (2024)
 Figure 8. Neuropathic Eye Pain Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Neuropathic Eye Pain Market Size Market Share by Type in 2024
 Figure 10. Neuropathic Eye Pain in Clinic
 Figure 11. Global Neuropathic Eye Pain Market: Clinic (2020-2025) & ($ millions)
 Figure 12. Neuropathic Eye Pain in Hospital
 Figure 13. Global Neuropathic Eye Pain Market: Hospital (2020-2025) & ($ millions)
 Figure 14. Neuropathic Eye Pain in Others
 Figure 15. Global Neuropathic Eye Pain Market: Others (2020-2025) & ($ millions)
 Figure 16. Global Neuropathic Eye Pain Market Size Market Share by Application in 2024
 Figure 17. Global Neuropathic Eye Pain Revenue Market Share by Player in 2024
 Figure 18. Global Neuropathic Eye Pain Market Size Market Share by Region (2020-2025)
 Figure 19. Americas Neuropathic Eye Pain Market Size 2020-2025 ($ millions)
 Figure 20. APAC Neuropathic Eye Pain Market Size 2020-2025 ($ millions)
 Figure 21. Europe Neuropathic Eye Pain Market Size 2020-2025 ($ millions)
 Figure 22. Middle East & Africa Neuropathic Eye Pain Market Size 2020-2025 ($ millions)
 Figure 23. Americas Neuropathic Eye Pain Value Market Share by Country in 2024
 Figure 24. United States Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 25. Canada Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 26. Mexico Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 27. Brazil Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 28. APAC Neuropathic Eye Pain Market Size Market Share by Region in 2024
 Figure 29. APAC Neuropathic Eye Pain Market Size Market Share by Type (2020-2025)
 Figure 30. APAC Neuropathic Eye Pain Market Size Market Share by Application (2020-2025)
 Figure 31. China Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 32. Japan Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 33. South Korea Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 34. Southeast Asia Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 35. India Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 36. Australia Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 37. Europe Neuropathic Eye Pain Market Size Market Share by Country in 2024
 Figure 38. Europe Neuropathic Eye Pain Market Size Market Share by Type (2020-2025)
 Figure 39. Europe Neuropathic Eye Pain Market Size Market Share by Application (2020-2025)
 Figure 40. Germany Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 41. France Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 42. UK Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 43. Italy Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 44. Russia Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 45. Middle East & Africa Neuropathic Eye Pain Market Size Market Share by Region (2020-2025)
 Figure 46. Middle East & Africa Neuropathic Eye Pain Market Size Market Share by Type (2020-2025)
 Figure 47. Middle East & Africa Neuropathic Eye Pain Market Size Market Share by Application (2020-2025)
 Figure 48. Egypt Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 49. South Africa Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 50. Israel Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 51. Turkey Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 52. GCC Countries Neuropathic Eye Pain Market Size Growth 2020-2025 ($ millions)
 Figure 53. Americas Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 54. APAC Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 55. Europe Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 56. Middle East & Africa Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 57. United States Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 58. Canada Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 59. Mexico Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 60. Brazil Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 61. China Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 62. Japan Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 63. Korea Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 64. Southeast Asia Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 65. India Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 66. Australia Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 67. Germany Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 68. France Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 69. UK Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 70. Italy Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 71. Russia Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 72. Egypt Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 73. South Africa Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 74. Israel Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 75. Turkey Neuropathic Eye Pain Market Size 2026-2031 ($ millions)
 Figure 76. Global Neuropathic Eye Pain Market Size Market Share Forecast by Type (2026-2031)
 Figure 77. Global Neuropathic Eye Pain Market Size Market Share Forecast by Application (2026-2031)
 Figure 78. GCC Countries Neuropathic Eye Pain Market Size 2026-2031 ($ millions)

Companies Mentioned

OKYO Pharma

Ocular Therapeutix, Inc.

IACTA Pharmaceuticals, Inc.

Sun Pharmaceutical Industries Ltd

Novartis AG

SALVAT

AbbVie Inc

Bausch &Lomb Incorporated

Kala Pharmaceuticals

Spectra Vision Care

AlconLaboratories

BRIM Biotechnology Inc

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff